Case Control Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Dec 14, 2024; 30(46): 4880-4903
Published online Dec 14, 2024. doi: 10.3748/wjg.v30.i46.4880
Figure 2
Figure 2 The distribution of genotype or haplotype combinations in each patient/participant group, in which haplotype A/G-G-G (in order of variation: Rs2856718, rs3077, rs9277535) had the highest frequency, especially in the hepatocellular carcinoma group (19. 1%, 48/250 patients). A: The distribution of genotype or haplotype combinations following the number of patients; B: The distribution of genotype or haplotype combinations following the prevalence (%).